Timothy V. Johnson, MD, Jennifer DeLong, PA; Viraj A. Master, MD, PhD January 16, 2012
Biochemical markers of inflammation, specifically CRP, serve as adjuncts to TNM staging
to help identify patients at increased risk for recurrence of kidney cancer.